7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan

Table 1

Demographic data and endoscopic appearance of 7-day concomitant therapy.

Characteristics	7-day concomitant therapy group (𝑛=319)
Age (yr) (mean ± SD)	53±12
Gender (male/female)	189/130
Smoking	71 (22.3%)
Alcohol consumption	24 (7.5%)
Ingestion of coffee	81 (25.4%)
Ingestion of tea	124 (38.9%)
NSAID use	16 (5%)
Underlying disease	80 (25.1%)
Endoscopic findings
Gastritis	98 (30.7%)
Gastric ulcer	100 (31.3%)
Duodenal ulcer	56 (17.6%)
Gastric ulcer + duodenal ulcer	65 (20.4%)